Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.76 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.62 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9257479 | 1.00 | CYP1A2 (0.76) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16264662 | 0.96 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16264592 | 0.96 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL16264624 | 0.96 | CYP1A2 (0.71) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| Hydrochloric Acid SCHEMBL29778322 | 0.95 | CYP1A2 (0.74) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| Hydrochloric Acid SCHEMBL29778283 | 0.95 | CYP1A2 (0.74) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| Hydrochloric Acid SCHEMBL29778333 | 0.95 | CYP1A2 (0.74) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL20428086 | 0.93 | CYP1A2 (0.69) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL21800079 | 0.92 | CYP1A2 (0.66) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 | |
| SCHEMBL21799546 | 0.92 | CYP1A2 (0.66) | CYP1A2CYP2D6CYP2C19CHRM2HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2943464-B1 | AMINE FOR LOW-EMISSION EPOXY RESIN PRODUCTS | SIKA TECH AG (CH) | 2017-03-01 | — | — | EP | disclosed |
| US-9580381-B2 | Amine for low-emission epoxy resin products | SIKA TECHNOLOGY AG (CH) | 2017-02-28 | — | — | US | disclosed |
| US-20150344406-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN PRODUCTS | SIKA TECHNOLOGY AG (CH) | 2015-12-03 | — | — | US | disclosed |
| EP-2752403-A1 | Amine for low-emission epoxy resin products | Sika Technology AG (CH) | 2014-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344406-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN PRODUCTS | EPHX2, ADAR, AAAS | CYP1A2 914/4885CYP2D6 2971/4885CYP2C19 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.